Neomycin And Polymyxin B Sulfates And Dexamethasone Suspension
Product Images NDC 61314-630

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Neomycin And Polymyxin B Sulfates And Dexamethasone (NDC 61314-630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neo Polyb Dex Suspension 5ml

This is a description of a medication with NDC number 61314-630-06. The medication is an ophthalmic suspension containing Neomycin and Polymyxin B Sulfates, and Dexamethasone. It is manufactured by Alcon Laboratories in Fort Worth, Texas. The medication is used to prevent or treat eye infections. The medication comes with a warning not to touch the dropper to avoid contamination. The medication should be shaken before use, and be kept in storage upright at a temperature of 46 to 80°F. The GTIN code for the medication is 00361314630063.*

FDA Label Image

Dexamethasone-chemical (Dexamethasone Chemical)

FDA Label Image

Neomycin (Neomycin)

FDA Label Image

Polymyxinb (Polymyxinb)

The text appears to be a combination of amino acids and chemical compounds. It includes the names of various amino acids such as L-Thr, L-DAB, D-Phe, and L-Leu. It also mentions Polymyxin B1, B2, B3, and B1-1 which are chemical compounds. The text provides a formula for DAB which is 2,4-diaminobutanoic acid. However, it appears to be a partial sequence or code and lacks a coherent description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.